Literature DB >> 19635907

A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

Aisha N Hasan1, Wouter J Kollen, Deepa Trivedi, Annamalai Selvakumar, Bo Dupont, Michel Sadelain, Richard J O'Reilly.   

Abstract

Adoptive transfer of virus-specific T cells can treat infections complicating allogeneic hematopoietic cell transplants. However, autologous APCs are often limited in supply. In this study, we describe a panel of artificial APCs (AAPCs) consisting of murine 3T3 cells transduced to express human B7.1, ICAM-1, and LFA-3 that each stably express one of a series of six common HLA class I alleles. In comparative analyses, T cells sensitized with AAPCs expressing a shared HLA allele or autologous APCs loaded with a pool of 15-mer spanning the sequence of CMVpp65 produced similar yields of HLA-restricted CMVpp65-specific T cells; significantly higher yields could be achieved by sensitization with AAPCs transduced to express the CMVpp65 protein. T cells generated were CD8(+), IFN-gamma(+), and exhibited HLA-restricted CMVpp65-specific cytotoxicity. T cells sensitized with either peptide-loaded or transduced AAPCs recognized epitopes presented by each HLA allele known to be immunogenic in humans. Sensitization with AAPCs also permitted expansion of IFN-gamma(+) cytotoxic effector cells against subdominant epitopes that were either absent or in low frequencies in T cells sensitized with autologous APCs. This replenishable panel of AAPCs can be used for immediate sensitization and expansion of virus-specific T cells of desired HLA restriction for adoptive immunotherapy. It may be of particular value for recipients of transplants from HLA-disparate donors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635907      PMCID: PMC3079474          DOI: 10.4049/jimmunol.0804178

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

1.  Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.

Authors:  Sophia V Derdak; Hans J Kueng; Victoria M Leb; Alina Neunkirchner; Klaus G Schmetterer; Edith Bielek; Otto Majdic; Walter Knapp; Brian Seed; Winfried F Pickl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 2.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

3.  In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring.

Authors:  J Yuan; H F Gallardo; T Rasalan; R Ranganathan; J Wang; Y Zhang; K Panageas; R Stan; J W Young; A N Houghton; J D Wolchok
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

4.  Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC.

Authors:  Shigemi Sasawatari; Toshimasa Tadaki; Manami Isogai; Masashi Takahara; Mie Nieda; Kazuhiro Kakimi
Journal:  Immunol Cell Biol       Date:  2006-07-20       Impact factor: 5.126

5.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.

Authors:  Carolina Berger; Michael C Jensen; Peter M Lansdorp; Mike Gough; Carole Elliott; Stanley R Riddell
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

6.  Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants.

Authors:  Richard J O'Reilly; Ekaterina Doubrovina; Deepa Trivedi; Aisha Hasan; Wouter Kollen; Guenther Koehne
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects.

Authors:  Rosanna Vescovini; Claudia Biasini; Francesco F Fagnoni; Anna Rita Telera; Luca Zanlari; Mario Pedrazzoni; Laura Bucci; Daniela Monti; Maria Cristina Medici; Carlo Chezzi; Claudio Franceschi; Paolo Sansoni
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.

Authors:  Marcus O Butler; Jeng-Shin Lee; Sascha Ansén; Donna Neuberg; F Stephen Hodi; Andrew P Murray; Linda Drury; Alla Berezovskaya; Richard C Mulligan; Lee M Nadler; Naoto Hirano
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

9.  A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.

Authors:  Erika Assarsson; John Sidney; Carla Oseroff; Valerie Pasquetto; Huynh-Hoa Bui; Nicole Frahm; Christian Brander; Bjoern Peters; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

View more
  17 in total

Review 1.  Adoptive T cell therapy of cancer.

Authors:  Malcolm K Brenner; Helen E Heslop
Journal:  Curr Opin Immunol       Date:  2010-02-17       Impact factor: 7.486

2.  CARs on track in the clinic.

Authors:  Donald B Kohn; Gianpietro Dotti; Renier Brentjens; Barbara Savoldo; Michael Jensen; Laurence Jn Cooper; Carl H June; Steven Rosenberg; Michel Sadelain; Helen E Heslop
Journal:  Mol Ther       Date:  2011-03       Impact factor: 11.454

3.  Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.

Authors:  Ekaterina Doubrovina; Taissia Carpenter; Dmitry Pankov; Annamalai Selvakumar; Aisha Hasan; Richard J O'Reilly
Journal:  Blood       Date:  2012-05-23       Impact factor: 22.113

Review 4.  Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Authors:  Bipulendu Jena; Gianpietro Dotti; Laurence J N Cooper
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

Review 5.  Novel strategies for adoptive therapy following HLA disparate transplants.

Authors:  Richard J O'Reilly; Aisha Hasan; Ekaterina Doubrovina; Guenther Koehne; Susan Prockop
Journal:  Best Pract Res Clin Haematol       Date:  2011-09       Impact factor: 3.020

Review 6.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

Authors:  Edwin P Alyea; Daniel J DeAngelo; Jeffrey Moldrem; John M Pagel; Donna Przepiorka; Michel Sadelin; James W Young; Sergio Giralt; Michael Bishop; Stan Riddell
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

7.  Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.

Authors:  Guenther Koehne; Aisha Hasan; Ekaterina Doubrovina; Susan Prockop; Eleanor Tyler; Gloria Wasilewski; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-29       Impact factor: 5.742

Review 8.  Artificial antigen-presenting cells for use in adoptive immunotherapy.

Authors:  Cameron J Turtle; Stanley R Riddell
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

Review 9.  Use of humanized severe combined immunodeficient mice for human vaccine development.

Authors:  Gloria C Koo; Aisha Hasan; Richard J O'Reilly
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

10.  Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.

Authors:  A N Hasan; A Selvakumar; E Shabrova; X-R Liu; F Afridi; G Heller; I Riviere; M Sadelain; B Dupont; R J O'Reilly
Journal:  Clin Exp Immunol       Date:  2016-08-31       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.